Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo

Microvascular Research

Volumn 104, Issue , 2016, Pages 46-54

  Zimmerer, Rüdiger M ^a   Matthiesen, Peter ^a   Kreher, Fritjof ^a   Kampmann, Andreas ^a   Spalthoff, Simon ^a   Jehn, Philipp ^a   Bittermann, Gido ^b   Gellrich, Nils Claudius ^a   Tavassol, Frank ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Cancer stem cells; CD133; Dorsal skinfold chamber; In vivo fluorescence microscopy; Melanoma

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROM1 PROTEIN, HUMAN; PROM1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CAPILLARY DENSITY; CELL SEPARATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOLOGY; IN VIVO STUDY; MELANOMA CELL LINE; MELANOMA CELL LINE D10; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; ANIMAL; HEMODYNAMICS; HUMAN; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; INTRAVITAL MICROSCOPY; MELANOMA; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SCID MOUSE; TUMOR CELL LINE; VASCULARIZATION;

AC133 ANTIGEN; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; FEMALE; GLYCOPROTEINS; HEMODYNAMICS; HUMANS; IMMUNOMAGNETIC SEPARATION; INTRAVITAL MICROSCOPY; MELANOMA; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, FLUORESCENCE; MICROVESSELS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES;

EID: 84961752962     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2015.12.001     Document Type: Article

References (35)

1. Ajani J.A., et al. Cancer stem cells: the promise and the potential. Semin. Oncol. 2015, 42(Supplement 1):S3-S17.
2. Al-Hajj M., et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. 2003, 100:3983-3988.
3. Bittner M., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406:536-540.
4. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
5. Borovski T., et al. Cancer stem cell niche: the place to be. Cancer Res. 2011, 71:634-639.
6. Döme B., et al. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am. J. Pathol. 2007, 170:1-15.
7. Folkman J. Transplacental carcinogenesis by stilbestrol. N. Engl. J. Med. 1971, 285:404-405.
8. Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 1995, 333:1757-1763.
9. Fukumura D., et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 1995, 55:4824-4829.
10. Hendrix M.J.C., et al. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 2003, 3:411-421.
11. Kampmann A., et al. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds. Microvasc. Res. 2013, 90:71-79.
12. Lai C.-Y., et al. CD133(+) melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res. 2012, 72:5111-5118.
13. Laschke M.W., et al. Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization. J. Biomed. Mater. Res., Part B 2007, 82B:494-505.
14. Laschke M.W., et al. Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds. J. Biomed. Mater. Res. Part A 2008, 85A:397-407.
15. Mak A.B., et al. CD133-targeted niche-dependent therapy in cancer: a multipronged approach. Am. J. Pathol. 2014, 184:1256-1262.
16. Maniotis A.J., et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 1999, 155:739-752.
17. Menger M.D., et al. Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow". Am. J. Phys. 1992, 263:H1892-H1900.
18. Monzani E., et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 2007, 43:935-946.
19. Piali L., et al. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med. 1995, 181:811-816.
20. Roesch A., et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
21. Rücker M., et al. Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery 2001, 129:292-301.
22. Schatton T., et al. Identification of cells initiating human melanomas. Nature 2008, 451:345-349.
23. Schumann P., et al. Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. Microvasc. Res. 2009, 78:180-190.
24. Schumann P., et al. Comparably accelerated vascularization by preincorporation of aortic fragments and mesenchymal stem cells in implanted tissue engineering constructs. J. Biomed. Mater. Res. A 2011, 97:383-394.
25. Schumann P., et al. Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel. J. Biomed. Mater. Res. A 2014, 102:1652-1662.
26. Seftor E., et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis 2002, 19:233-246.
27. Shmelkov S.V., et al. CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors. J. Clin. Invest. 2008, 118:2111-2120.
28. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
29. Stoetzer M., et al. Subperiosteal preparation using a new piezoelectric device: a histological examination. GMS Interdiscip. Plast. Reconstr. Surg. DGPW 2014, (3, Doc18).
30. Tang W., et al. miR-27a regulates endothelial differentiation of breast cancer stem like cells. Oncogene 2014, 33:2629-2638.
31. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 2011, 17:1359-1370.
32. Zhang S., et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68:4311-4320.
33. Zimmerer R.M., et al. Functional features of cancer stem cells in melanoma cell lines. Cancer Cell Int. 2013, 13:78.
34. Zocchi M.R., Poggi A. Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. J. Natl. Cancer Inst. 1993, 85:246-247.
35. Zocchi M.R., et al. Involvement of CD56/N-CAM molecule in the adhesion of human solid tumor cell lines to endothelial cells. Exp. Cell Res. 1993, 204:130-135.